Next Generation Kinase Inhibitors Summit

Temi della conferenza
Celebrating 20 years of FDA approval and high efficacy profiles, kinase inhibitors have changed the face of oncology treatment. However, increasing resistance and safety issues limit the success of existing kinase inhibitor classes.

Professional congress organizer (PCO)
Hanson Wade

Annotazioni
Brochure: https://go.evvnt.com/944626-0?pid=4832

Speakers: Leslie Cousens, Senior Director, Search and Evaluation, Respiratory and Immunology, AstraZeneca, Markus Queisser, Scientific Director, GlaxoSmithKline, and more.

https://go.evvnt.com/944626-1?pid=4832

Mr. Hanson Wade